ArticleArchives of virology2025
Genotype analysis of severe fever with thrombocytopenia syndrome viruses in Gyeonggi Province of South Korea from 2017 to 2022.
Article in Archives of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne infectious disease that was first identified in South Korea in 2013. To investigate the SFTS virus (SFTSV) genotypes in Gyeonggi Province, SFTSV detected in 126 patient serum samples collected between 2017 and 2022 was subjected to genetic analysis. Among SFTSV genotypes A to F, SFTSV genotype B was the most common, found in a total of 101 cases (80.2%). Within genotype B, there were 85 cases of subgenotype B-1 (67.5%) and 16 cases of subgenotype B-2 (12.7%), but no cases of subgenotype B-3. Five cases of genotype F (3.9%), one of genotype C (0.8%), and one of genotype D (0.8%) were identified. No genotype A or E strains were found. Of the 108 patients for whom epidemiological information was available, 16 (14.8%) died, 75 (68.5%) recovered, and the outcome was unknown for 18 (16.7%) patients. Although the number of samples tested was not large enough to allow a concrete conclusion, subgenotype B-1 showed the highest fatality rate (16.5%). The high prevalence and lethality of SFTSV subgenotype B-1 in a local region of South Korea showed that continuous monitoring of SFTSV genotypes is necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.